D-208-2013 Class III Terminated

Recalled by Novartis Consumer Health — Lincoln, NE

FDA drug recall D-208-2013 was initiated by Novartis Consumer Health on Mar 7, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 91,872/1-oz. tubes and 94,464/2-oz. tubes.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2013
Initiation Date
Mar 7, 2013
Termination Date
Nov 26, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
91,872/1-oz. tubes and 94,464/2-oz. tubes

Product description

Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Distribution pattern

Nationwide and Panama

Code information

Lot #: a) 10109149, 10111499, 10117160, 10119603, and 10121763, Exp 4/13 to 8/13; b) 10109148, 10112258, 10113806, 10115615, 10117161, 10119604, 10119605, 10121782, and 10122762, Exp 3/13 to 9/13.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-208-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-208-2013. Report a data issue: hello@regdatalab.com.